A Study to Assess Safety, Tolerability and Pharmacokinetics of GLPG2451 in Healthy Male Subjects
Clinical trial NCT03214614 · COMPLETED
Trial details
- NCT number
- NCT03214614
- Sponsor
- Lakefront Biotherapeutics NV
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-14
- Primary completion
- 2017-08-25
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.